Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials

Medicine (United States)

Volumn 95, Issue 31, 2016, Pages

  Wang, Yizhong ^a   Li, Xiaolu ^a   Ge, Ting ^a   Xiao, Yongmei ^a   Liao, Yang ^a   Cui, Yun ^a   Zhang, Yucai ^a   Ho, Wenzhe ^b   Yu, Guangjun ^a   Zhang, Ting ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

children; probiotics; randomized controlled trials; respiratory tract infections

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; APPETITE DISORDER; COCHRANE LIBRARY; CONSTIPATION; DIARRHEA; DISEASE DURATION; DRY SKIN; EMBASE; GASTROESOPHAGEAL REFLUX; HUMAN; INFECTION PREVENTION; MEDLINE; META ANALYSIS; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SCHOOL ATTENDANCE; SUPPLEMENTATION; SYSTEMATIC REVIEW; URTICARIA; VOMITING; WEB OF SCIENCE; ABSENTEEISM; CHILD; RESPIRATORY TRACT INFECTIONS;

ABSENTEEISM; CHILD; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS;

EID: 84983249378     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004509     Document Type: Review

References (78)

1. Vesa S, Kleemola M, Blomqvist S, et al. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J 2001;20:574-81.
2. Nokso-Koivisto J, Pitkaranta A, Blomqvist S, et al. Viral etiology of frequently recurring respiratory tract infections in children. Clin Infect Dis 2002;35:540-6.
3. Nicholson KG, McNally T, Silverman M, et al. Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine 2006;24:102-8.
4. Massin MM, Montesanti J, Gerard P, et al. Spectrum and frequency of illness presenting to a pediatric emergency department. Acta Clin Belg 2006;61:161-5.
5. Cabral C, Ingram J, Lucas PJ, et al. Influence of clinical communication on parents' antibiotic expectations for children with respiratory tract infections. Ann Fam Med 2016;14:141-7.
6. Marc C, Vrignaud B, Levieux K, et al. Inappropriate prescription of antibiotics in pediatric practice: analysis of the prescriptions in primary care. J Child Health Care 2016;pii: 1367493516643421. [Epub ahead of print].
7. Andrews T, Thompson M, Buckley Di, et al. Interventions to influence consulting and antibiotic use for acute respiratory tract infections in children: a systematic review and meta-analysis. PLoS One 2012;7: e30334.
8. Lange K, Buerger M, Stallmach A, et al. Effects of antibiotics on gut microbiota. Dig Dis 2016;34:260-8.
9. Ehlken B, Ihorst G, Lippert B, et al. Economic impact of communityacquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr 2005;164:607-15.
10. Lambert SB, Allen KM, Carter RC, et al. The cost of communitymanaged viral respiratory illnesses in a cohort of healthy preschool-aged children. Respir Res 2008;9:11.
11. Food and Agriculture Organization of the United Nations, World Health Organization. Guidelines for the Evaluation of Probiotics in Food. Joint FAO/WHO Working Group Report. London, Canada: Food and Agriculture Organization of the United Nations, World Health Organization; 2002. Available at: ftp://ftp. fao. org/es/esn/food/wgre port2. pdf. Accessed April 30 and May 1, 2002.
12. Szajewska H, Konarska Z, Kolodziej M. Probiotic bacterial and fungal strains: claims with evidence. Dig Dis 2016;34:251-9.
13. Schreck Bird A, Gregory PJ, Jalloh MA, et al. Probiotics for the treatment of infantile colic: a systematic review. J Pharm Pract 2016;pii: 0897190016634516. [Epub ahead of print].
14. Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organisation global guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012;46:468-81.
15. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut 2013;62:787-96.
16. Hickey L, Jacobs SE, Garland SM. Probiotics in neonatology. J Paediatr Child Health 2012;48:777-83.
17. Berin MC. Bugs versus bugs: probiotics, microbiome and allergy. Int Arch Allergy Immunol 2014;163:165-7.
18. Didari T, Mozaffari S, Nikfar S, et al. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol 2015;21:3072-84.
19. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health 2014;9:584-671.
20. Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012;7:e34938.
21. Abad CL, Safdar N. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections-a systematic review. J Chemother 2009;21:243-52.
22. Araujo GV, Oliveira Junior MH, Peixoto DM, et al. Probiotics for the treatment of upper and lower respiratory-tract infections in children: systematic review based on randomized clinical trials. J Pediatr (Rio J) 2015;91:413-27.
23. Dinleyici EC, Eren M, Ozen M, et al. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012;12:395-410.
24. Szajewska H, Skorka A, Ruszczynski M, et al. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013;38:467-76.
25. Szajewska H, Kolodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther 2015;42:1149-57.
26. Szajewska H, Urbanska M, Chmielewska A, et al. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes 2014;5:285-93.
27. Tabbers MM, Chmielewska A, Roseboom MG, et al. Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial. Pediatrics 2011;127: e1392-9.
28. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34.
29. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5. 1. 0 (Updated March 2011). Copenhagen, Denmark: The Cochrane Collaboration; 2011. Available at: www. cochrane-handbook. org.
30. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
31. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383-94.
32. Wan X,Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.
33. Cáceres P, Montes S, Vega N, et al. Effects of Lactobacillus rhamnosus HN001 on acute respiratory infections and intestinal secretory IgA in children. Pediatr Infect Dis J 2010;5:353-62.
34. Cazzola M, Pham-Thi N, Kerihuel JC, et al. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv Respir Dis 2010;4:271-8.
35. Cohen R, Martin E, de La Rocque F, et al. Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study. Pediatr Infect Dis J 2013;32:810-4.
36. Gerasimov SV, Ivantsiv VA, Bobryk LM, et al. Role of short-term use of L. acidophilus DDS-1 and B. lactis UABLA-12 in acute respiratory infections in children: a randomized controlled trial. Eur J Clin Nutr 2016;70:463-9.
37. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001;322:1327.
38. Hatakka K, Blomgren K, Pohjavuori S, et al. Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebocontrolled randomised study. Clin Nutr 2007;26:314-21.
39. Hojsak I, Snovak N, Abdovic S, et al. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 2010;29:312-6.
40. Hojsak I, Abdovic S, Szajewska H, et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010;125:e1171-1177.
41. Hojsak I, Tokic Pivac V, Mocic Pavic A, et al. Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 2015;101:680-4.
42. Hojsak I, Mocic Pavic A, Kos T, et al. Bifidobacterium animalis subsp. lactis in prevention of common infections in healthy children attending day care centers-randomized, double blind, placebo-controlled study. Clin Nutr 2016;35:587-91.
43. Kloster Smerud H, Ramstad Kleiveland C, Roll Mosland A, et al. Effect of a probiotic milk product on gastrointestinal and respiratory infections in children attending day-care. Microb Ecol Health Dis 2008;20:80-5.
44. KumpuM, Kekkonen RA, Kautiainen H, et al. Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 2012;66:1020-3.
45. Leyer GJ, Li S, Mubasher ME, et al. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 2009;124:e172-9.
46. Maldonado J, Canabate F, Sempere L, et al. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr 2012;54:55-61.
47. Merenstein D, Murphy M, Fokar A, et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, doubleblind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 2010;64:669-77.
48. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy-a randomised, double-blind, placebocontrolled study. Br J Nutr 2009;101:1722-6.
49. Rerksuppaphol S, Rerksuppaphol L. Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatr Int 2012;54:682-7.
50. Roos K, Hakansson EG, Holm S. Effect of recolonisation with interfering alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 2001;322:210-2.
51. Skovbjerg S, Roos K, Holm SE, et al. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child 2009;94:92-8.
52. Taipale T, Pienihakkinen K, Isolauri E, et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 2011;105:409-16.
53. Taipale TJ, Pienihakkinen K, Isolauri E, et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatr Res 2016;79:65-9.
54. Tano K, Grahn Hakansson E, Holm SE, et al. A nasal spray with alphahaemolytic streptococci as long term prophylaxis against recurrent otitis media. Int J Pediatr Otorhinolaryngol 2002;62:17-23.
55. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005;115:5-9.
56. Eccles MP, Grimshaw JM, Johnston M, et al. Applying psychological theories to evidence-based clinical practice: identifying factors predictive of managing upper respiratory tract infections without antibiotics. Implement Sci 2007;2:26.
57. van Riel D, Munster VJ, deWit E, et al. H5N1 virus attachment to lower respiratory tract. Science 2006;312:399.
58. Kyu HH, Pinho C, Wagner JA, et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the Global Burden of Disease 2013 Study. JAMA Pediatr 2016;170:267-87.
59. Thompson M, Vodicka TA, Blair PS, et al. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ 2013;347:f7027.
60. Laurent C, Dugue AE, Brouard J, et al. Viral epidemiology and severity of respiratory infections in infants in 2009: a prospective study. Pediatr Infect Dis J 2012;31:827-31.
61. Alves Galvao MG, Rocha Crispino Santos MA, Alves da Cunha AJ. Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age. Cochrane Database Syst Rev 2016;2:CD007880.
62. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999; 65:4949-56.
63. Ahrne S, Hagslatt ML. Effect of lactobacilli on paracellular permeability in the gut. Nutrients 2011;3:104-17.
64. Morais MB, Jacob CM. The role of probiotics and prebiotics in pediatric practice. J Pediatr (Rio J) 2006;82(5 suppl):S189-97.
65. Hidalgo-Cantabrana C, Sanchez B, Milani C, et al. Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp. Appl Environ Microbiol 2014;80:9-18.
66. Guillemard E, Tanguy J, Flavigny A, et al. Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial. J Am Coll Nutr 2010;29:455-68.
67. Oliva S, Di Nardo G, Ferrari F, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012;35:327-34.
68. Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br JNutr 2002;88(suppl 1):S39-49.
69. Dinleyici EC, Dalgic N, Guven S, et al. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr (Rio J) 2015;91:392-6.
70. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 2010;126:e526-33.
71. Pineton de Chambrun G, Neut C, Chau A, et al. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome. Dig Liver Dis 2015;47:119-24.
72. Kang EJ, Kim SY, Hwang IH, et al. The effect of probiotics on prevention of common cold: a meta-analysis of randomized controlled trial studies. Korean J Fam Med 2013;34:2-10.
73. Liu S,Hu P,DuX, et al. Lactobacillus rhamnosusGGsupplementation for preventing respiratory infections in children: a meta-analysis of randomized, placebo-controlled trials. Indian Pediatr 2013; 50:377-81.
74. HaoQ,Dong BR,WuT. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2015;2:CD006895.
75. Ozen M, Kocabas Sandal G, Dinleyici EC. Probiotics for the prevention of pediatric upper respiratory tract infections: a systematic review. Expert Opin Biol Ther 2015;15:9-20.
76. Esposito S, Rigante D, Principi N. Do children's upper respiratory tract infections benefit from probiotics? BMC Infect Dis 2014;14:194.
77. Vouloumanou EK, Makris GC, Karageorgopoulos DE, et al. Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents 2009;34: 197. e1-e10.
78. King S, Glanville J, Sanders ME, et al. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and metaanalysis. Br J Nutr 2014;112:41-54.